Question 1

Who are the top researchers at Synovo (Germany)?

Accepted Answer

Ranked on the quality score, Michael W. M. Burnet lead among researchers whose main affiliation is Synovo (Germany).

Question 2

What are the most cited papers from Synovo (Germany)?

Accepted Answer

The most cited paper from Synovo (Germany) is "The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction" (Philipp Schwabl, Eva Hambruch, Berit Seeland et al., 2016), with 176 citations. Next come "Quorum-Quenching and Matrix-Degrading Enzymes in Multilayer Coatings Synergistically Prevent Bacterial Biofilm Formation on Urinary Catheters" (159) and "Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion" (128).

Question 3

Which research topics does Synovo (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Immune Response and Inflammation, Immune Cell Function and Interaction, Cytokine Signaling Pathways and Interactions and Melanoma and MAPK Pathways.

Question 4

Which keywords describe research at Synovo (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Therapeutic Targets, Neuroprotection, Tumor Microenvironment, Neuroinflammation, Innate Immunity, Adenosine Receptors and Purinergic Signalling.

Question 5

Which fields of science does Synovo (Germany) work in?

Accepted Answer

In all years, 51% of research at Synovo (Germany) is in Life Sciences, 44% in Health Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (11%). It does 2.2× the world's share of Life Sciences.

Question 6

Is Synovo (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 77% higher than in 2018-2021.